Report Detail

Other Global Rosuvastatin (CAS 287714-41-4) Market Insights, Forecast to 2025

  • RnM3154217
  • |
  • 20 March, 2019
  • |
  • Global
  • |
  • 118 Pages
  • |
  • QYResearch
  • |
  • Other

Global Rosuvastatin (CAS 287714-41-4) market size will increase to Million US$ by 2025, from Million US$ in 2018, at a CAGR of during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Rosuvastatin (CAS 287714-41-4).

This report researches the worldwide Rosuvastatin (CAS 287714-41-4) market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global Rosuvastatin (CAS 287714-41-4) breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

The following manufacturers are covered in this report:
Anuh Pharma LTD
Anwita Drugs & Chemicals Pvt Ltd
Aspen Biopharma Labs Pvt Ltd
DSM Sinochem Pharmaceuticals
Jeil Pharmaceutical Co., Ltd
Jubilant Life Sciences Limited
Kores India Limited
Titan Laboratories Pvt Ltd

Rosuvastatin (CAS 287714-41-4) Breakdown Data by Type
High Purity
Low Purity
Rosuvastatin (CAS 287714-41-4) Breakdown Data by Application
Tablets
Others

Rosuvastatin (CAS 287714-41-4) Production Breakdown Data by Region
United States
Europe
China
Japan
Other Regions

Rosuvastatin (CAS 287714-41-4) Consumption Breakdown Data by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
Central & South America
Brazil
Rest of South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa

The study objectives are:
To analyze and research the global Rosuvastatin (CAS 287714-41-4) capacity, production, value, consumption, status and forecast;
To focus on the key Rosuvastatin (CAS 287714-41-4) manufacturers and study the capacity, production, value, market share and development plans in next few years.
To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Rosuvastatin (CAS 287714-41-4) :
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    Global Rosuvastatin (CAS 287714-41-4) Market Research Report 2019-2025, by Manufacturers, Regions, Types and Applications

      1 Study Coverage

      • 1.1 Rosuvastatin (CAS 287714-41-4) Product
      • 1.2 Key Market Segments in This Study
      • 1.3 Key Manufacturers Covered
      • 1.4 Market by Type
        • 1.4.1 Global Rosuvastatin (CAS 287714-41-4) Market Size Growth Rate by Type
        • 1.4.2 High Purity
        • 1.4.3 Low Purity
      • 1.5 Market by Application
        • 1.5.1 Global Rosuvastatin (CAS 287714-41-4) Market Size Growth Rate by Application
        • 1.5.2 Tablets
        • 1.5.3 Others
      • 1.6 Study Objectives
      • 1.7 Years Considered

      2 Executive Summary

      • 2.1 Global Rosuvastatin (CAS 287714-41-4) Production
        • 2.1.1 Global Rosuvastatin (CAS 287714-41-4) Revenue 2014-2025
        • 2.1.2 Global Rosuvastatin (CAS 287714-41-4) Production 2014-2025
        • 2.1.3 Global Rosuvastatin (CAS 287714-41-4) Capacity 2014-2025
        • 2.1.4 Global Rosuvastatin (CAS 287714-41-4) Marketing Pricing and Trends
      • 2.2 Rosuvastatin (CAS 287714-41-4) Growth Rate (CAGR) 2019-2025
      • 2.3 Analysis of Competitive Landscape
        • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        • 2.3.2 Key Rosuvastatin (CAS 287714-41-4) Manufacturers
      • 2.4 Market Drivers, Trends and Issues
      • 2.5 Macroscopic Indicator
        • 2.5.1 GDP for Major Regions
        • 2.5.2 Price of Raw Materials in Dollars: Evolution

      3 Market Size by Manufacturers

      • 3.1 Rosuvastatin (CAS 287714-41-4) Production by Manufacturers
        • 3.1.1 Rosuvastatin (CAS 287714-41-4) Production by Manufacturers
        • 3.1.2 Rosuvastatin (CAS 287714-41-4) Production Market Share by Manufacturers
      • 3.2 Rosuvastatin (CAS 287714-41-4) Revenue by Manufacturers
        • 3.2.1 Rosuvastatin (CAS 287714-41-4) Revenue by Manufacturers (2014-2019)
        • 3.2.2 Rosuvastatin (CAS 287714-41-4) Revenue Share by Manufacturers (2014-2019)
      • 3.3 Rosuvastatin (CAS 287714-41-4) Price by Manufacturers
      • 3.4 Mergers & Acquisitions, Expansion Plans

      4 Rosuvastatin (CAS 287714-41-4) Production by Regions

      • 4.1 Global Rosuvastatin (CAS 287714-41-4) Production by Regions
        • 4.1.1 Global Rosuvastatin (CAS 287714-41-4) Production Market Share by Regions
        • 4.1.2 Global Rosuvastatin (CAS 287714-41-4) Revenue Market Share by Regions
      • 4.2 United States
        • 4.2.1 United States Rosuvastatin (CAS 287714-41-4) Production
        • 4.2.2 United States Rosuvastatin (CAS 287714-41-4) Revenue
        • 4.2.3 Key Players in United States
        • 4.2.4 United States Rosuvastatin (CAS 287714-41-4) Import & Export
      • 4.3 Europe
        • 4.3.1 Europe Rosuvastatin (CAS 287714-41-4) Production
        • 4.3.2 Europe Rosuvastatin (CAS 287714-41-4) Revenue
        • 4.3.3 Key Players in Europe
        • 4.3.4 Europe Rosuvastatin (CAS 287714-41-4) Import & Export
      • 4.4 China
        • 4.4.1 China Rosuvastatin (CAS 287714-41-4) Production
        • 4.4.2 China Rosuvastatin (CAS 287714-41-4) Revenue
        • 4.4.3 Key Players in China
        • 4.4.4 China Rosuvastatin (CAS 287714-41-4) Import & Export
      • 4.5 Japan
        • 4.5.1 Japan Rosuvastatin (CAS 287714-41-4) Production
        • 4.5.2 Japan Rosuvastatin (CAS 287714-41-4) Revenue
        • 4.5.3 Key Players in Japan
        • 4.5.4 Japan Rosuvastatin (CAS 287714-41-4) Import & Export
      • 4.6 Other Regions
        • 4.6.1 South Korea
        • 4.6.2 India
        • 4.6.3 Southeast Asia

      5 Rosuvastatin (CAS 287714-41-4) Consumption by Regions

      • 5.1 Global Rosuvastatin (CAS 287714-41-4) Consumption by Regions
        • 5.1.1 Global Rosuvastatin (CAS 287714-41-4) Consumption by Regions
        • 5.1.2 Global Rosuvastatin (CAS 287714-41-4) Consumption Market Share by Regions
      • 5.2 North America
        • 5.2.1 North America Rosuvastatin (CAS 287714-41-4) Consumption by Application
        • 5.2.2 North America Rosuvastatin (CAS 287714-41-4) Consumption by Countries
        • 5.2.3 United States
        • 5.2.4 Canada
        • 5.2.5 Mexico
      • 5.3 Europe
        • 5.3.1 Europe Rosuvastatin (CAS 287714-41-4) Consumption by Application
        • 5.3.2 Europe Rosuvastatin (CAS 287714-41-4) Consumption by Countries
        • 5.3.3 Germany
        • 5.3.4 France
        • 5.3.5 UK
        • 5.3.6 Italy
        • 5.3.7 Russia
      • 5.4 Asia Pacific
        • 5.4.1 Asia Pacific Rosuvastatin (CAS 287714-41-4) Consumption by Application
        • 5.4.2 Asia Pacific Rosuvastatin (CAS 287714-41-4) Consumption by Countries
        • 5.4.3 China
        • 5.4.4 Japan
        • 5.4.5 South Korea
        • 5.4.6 India
        • 5.4.7 Australia
        • 5.4.8 Indonesia
        • 5.4.9 Thailand
        • 5.4.10 Malaysia
        • 5.4.11 Philippines
        • 5.4.12 Vietnam
      • 5.5 Central & South America
        • 5.5.1 Central & South America Rosuvastatin (CAS 287714-41-4) Consumption by Application
        • 5.5.2 Central & South America Rosuvastatin (CAS 287714-41-4) Consumption by Countries
        • 5.5.3 Brazil
      • 5.6 Middle East and Africa
        • 5.6.1 Middle East and Africa Rosuvastatin (CAS 287714-41-4) Consumption by Application
        • 5.6.2 Middle East and Africa Rosuvastatin (CAS 287714-41-4) Consumption by Countries
        • 5.6.3 Turkey
        • 5.6.4 GCC Countries
        • 5.6.5 Egypt
        • 5.6.6 South Africa

      6 Market Size by Type

      • 6.1 Global Rosuvastatin (CAS 287714-41-4) Breakdown Dada by Type
      • 6.2 Global Rosuvastatin (CAS 287714-41-4) Revenue by Type
      • 6.3 Rosuvastatin (CAS 287714-41-4) Price by Type

      7 Market Size by Application

      • 7.1 Overview
      • 7.2 Global Rosuvastatin (CAS 287714-41-4) Breakdown Dada by Application
        • 7.2.1 Global Rosuvastatin (CAS 287714-41-4) Consumption by Application
        • 7.2.2 Global Rosuvastatin (CAS 287714-41-4) Consumption Market Share by Application (2014-2019)

      8 Manufacturers Profiles

      • 8.1 Anuh Pharma LTD
        • 8.1.1 Anuh Pharma LTD Company Details
        • 8.1.2 Company Description
        • 8.1.3 Capacity, Production and Value of Rosuvastatin (CAS 287714-41-4)
        • 8.1.4 Rosuvastatin (CAS 287714-41-4) Product Description
        • 8.1.5 SWOT Analysis
      • 8.2 Anwita Drugs & Chemicals Pvt Ltd
        • 8.2.1 Anwita Drugs & Chemicals Pvt Ltd Company Details
        • 8.2.2 Company Description
        • 8.2.3 Capacity, Production and Value of Rosuvastatin (CAS 287714-41-4)
        • 8.2.4 Rosuvastatin (CAS 287714-41-4) Product Description
        • 8.2.5 SWOT Analysis
      • 8.3 Aspen Biopharma Labs Pvt Ltd
        • 8.3.1 Aspen Biopharma Labs Pvt Ltd Company Details
        • 8.3.2 Company Description
        • 8.3.3 Capacity, Production and Value of Rosuvastatin (CAS 287714-41-4)
        • 8.3.4 Rosuvastatin (CAS 287714-41-4) Product Description
        • 8.3.5 SWOT Analysis
      • 8.4 DSM Sinochem Pharmaceuticals
        • 8.4.1 DSM Sinochem Pharmaceuticals Company Details
        • 8.4.2 Company Description
        • 8.4.3 Capacity, Production and Value of Rosuvastatin (CAS 287714-41-4)
        • 8.4.4 Rosuvastatin (CAS 287714-41-4) Product Description
        • 8.4.5 SWOT Analysis
      • 8.5 Jeil Pharmaceutical Co., Ltd
        • 8.5.1 Jeil Pharmaceutical Co., Ltd Company Details
        • 8.5.2 Company Description
        • 8.5.3 Capacity, Production and Value of Rosuvastatin (CAS 287714-41-4)
        • 8.5.4 Rosuvastatin (CAS 287714-41-4) Product Description
        • 8.5.5 SWOT Analysis
      • 8.6 Jubilant Life Sciences Limited
        • 8.6.1 Jubilant Life Sciences Limited Company Details
        • 8.6.2 Company Description
        • 8.6.3 Capacity, Production and Value of Rosuvastatin (CAS 287714-41-4)
        • 8.6.4 Rosuvastatin (CAS 287714-41-4) Product Description
        • 8.6.5 SWOT Analysis
      • 8.7 Kores India Limited
        • 8.7.1 Kores India Limited Company Details
        • 8.7.2 Company Description
        • 8.7.3 Capacity, Production and Value of Rosuvastatin (CAS 287714-41-4)
        • 8.7.4 Rosuvastatin (CAS 287714-41-4) Product Description
        • 8.7.5 SWOT Analysis
      • 8.8 Titan Laboratories Pvt Ltd
        • 8.8.1 Titan Laboratories Pvt Ltd Company Details
        • 8.8.2 Company Description
        • 8.8.3 Capacity, Production and Value of Rosuvastatin (CAS 287714-41-4)
        • 8.8.4 Rosuvastatin (CAS 287714-41-4) Product Description
        • 8.8.5 SWOT Analysis

      9 Production Forecasts

      • 9.1 Rosuvastatin (CAS 287714-41-4) Production and Revenue Forecast
        • 9.1.1 Global Rosuvastatin (CAS 287714-41-4) Production Forecast 2019-2025
        • 9.1.2 Global Rosuvastatin (CAS 287714-41-4) Revenue Forecast 2019-2025
      • 9.2 Rosuvastatin (CAS 287714-41-4) Production and Revenue Forecast by Regions
        • 9.2.1 Global Rosuvastatin (CAS 287714-41-4) Revenue Forecast by Regions
        • 9.2.2 Global Rosuvastatin (CAS 287714-41-4) Production Forecast by Regions
      • 9.3 Rosuvastatin (CAS 287714-41-4) Key Producers Forecast
        • 9.3.1 United States
        • 9.3.2 Europe
        • 9.3.3 China
        • 9.3.4 Japan
      • 9.4 Forecast by Type
        • 9.4.1 Global Rosuvastatin (CAS 287714-41-4) Production Forecast by Type
        • 9.4.2 Global Rosuvastatin (CAS 287714-41-4) Revenue Forecast by Type

      10 Consumption Forecast

      • 10.1 Consumption Forecast by Application
      • 10.2 Rosuvastatin (CAS 287714-41-4) Consumption Forecast by Regions
      • 10.3 North America Market Consumption Forecast
        • 10.3.1 North America Rosuvastatin (CAS 287714-41-4) Consumption Forecast by Countries 2019-2025
        • 10.3.2 United States
        • 10.3.3 Canada
        • 10.3.4 Mexico
      • 10.4 Europe Market Consumption Forecast
        • 10.4.1 Europe Rosuvastatin (CAS 287714-41-4) Consumption Forecast by Countries 2019-2025
        • 10.4.2 Germany
        • 10.4.3 France
        • 10.4.4 UK
        • 10.4.5 Italy
        • 10.4.6 Russia
      • 10.5 Asia Pacific Market Consumption Forecast
        • 10.5.1 Asia Pacific Rosuvastatin (CAS 287714-41-4) Consumption Forecast by Countries 2019-2025
        • 10.5.2 China
        • 10.5.3 Japan
        • 10.5.4 Korea
        • 10.5.5 India
        • 10.5.6 Australia
        • 10.5.7 Indonesia
        • 10.5.8 Thailand
        • 10.5.9 Malaysia
        • 10.5.10 Philippines
        • 10.5.11 Vietnam
      • 10.6 Central & South America Market Consumption Forecast
        • 10.6.1 Central & South America Rosuvastatin (CAS 287714-41-4) Consumption Forecast by Country 2019-2025
        • 10.6.2 Brazil
      • 10.7 Middle East and Africa Market Consumption Forecast
        • 10.7.1 Middle East and Africa Rosuvastatin (CAS 287714-41-4) Consumption Forecast by Countries 2019-2025
        • 10.7.2 Middle East and Africa
        • 10.7.3 Turkey
        • 10.7.4 GCC Countries
        • 10.7.5 Egypt
        • 10.7.6 South Africa

      11 Upstream, Industry Chain and Downstream Customers Analysis

      • 11.1 Analysis of Rosuvastatin (CAS 287714-41-4) Upstream Market
        • 11.1.1 Rosuvastatin (CAS 287714-41-4) Key Raw Material
        • 11.1.2 Typical Suppliers of Key Rosuvastatin (CAS 287714-41-4) Raw Material
        • 11.1.3 Rosuvastatin (CAS 287714-41-4) Raw Material Market Concentration Rate
      • 11.2 Rosuvastatin (CAS 287714-41-4) Industry Chain Analysis
      • 11.3 Marketing & Distribution
      • 11.4 Rosuvastatin (CAS 287714-41-4) Distributors
      • 11.5 Rosuvastatin (CAS 287714-41-4) Customers

      12 Opportunities & Challenges, Threat and Affecting Factors

      • 12.1 Market Opportunities
      • 12.2 Market Challenges
      • 12.3 Porter's Five Forces Analysis

      13 Key Findings

        14 Appendix

        • 14.1 Research Methodology
          • 14.1.1 Methodology/Research Approach
          • 14.1.2 Data Source
        • 14.2 Author Details

        Summary:
        Get latest Market Research Reports on Rosuvastatin (CAS 287714-41-4) . Industry analysis & Market Report on Rosuvastatin (CAS 287714-41-4) is a syndicated market report, published as Global Rosuvastatin (CAS 287714-41-4) Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Rosuvastatin (CAS 287714-41-4) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,900.00
        $5,850.00
        $7,800.00
        3,108.30
        4,662.45
        6,216.60
        3,623.10
        5,434.65
        7,246.20
        597,597.00
        896,395.50
        1,195,194.00
        325,416.00
        488,124.00
        650,832.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report